Ebola: Difference between revisions

Jump to navigation Jump to search
Line 72: Line 72:


On [[November 30]], [[2007]], the [[Uganda]] Ministry of Health confirmed an outbreak of Ebola in the [[Bundibugyo District]].  After confirmation of samples tested by the United States National Reference Laboratories and the Centers for Disease Control, the World Health Organization confirmed the presence of a new species of the Ebola virus.<ref>{{cite news |first= |last= |authorlink= |coauthors= |title=Uganda: Deadly Ebola Outbreak Confirmed - UN |url=http://allafrica.com/stories/200711301070.html |work=UN News Service |publisher= |date=2007-11-30 |accessdate=2008-02-25 }}</ref> The epidemic came to an official end on February 20, 2008.  149 cases of this new strain were reported and 37 of those led to deaths.
On [[November 30]], [[2007]], the [[Uganda]] Ministry of Health confirmed an outbreak of Ebola in the [[Bundibugyo District]].  After confirmation of samples tested by the United States National Reference Laboratories and the Centers for Disease Control, the World Health Organization confirmed the presence of a new species of the Ebola virus.<ref>{{cite news |first= |last= |authorlink= |coauthors= |title=Uganda: Deadly Ebola Outbreak Confirmed - UN |url=http://allafrica.com/stories/200711301070.html |work=UN News Service |publisher= |date=2007-11-30 |accessdate=2008-02-25 }}</ref> The epidemic came to an official end on February 20, 2008.  149 cases of this new strain were reported and 37 of those led to deaths.
==Life Cycle==
* Virus attaches to host receptors through the GP (glycoprotein) surface [[peplomer]] and is endocytosed into vesicles in the host cell.
* Fusion of virus membrane with the vesicle membrane occurs; nucleocapsid is released into the cytoplasm.
* The encapsidated, negative-sense genomic ssRNA is used as a template for the synthesis ( 3' - 5') of polyadenylated, monocistronic mRNAs.
* Translation of the mRNA into viral proteins occurs using the host cell's machinery.
* Post-translational processing of viral proteins occurs. GP0 (glycoprotein precursor) is cleaved to GP1 and GP2, which are heavily glycosylated. These    two molecules assemble, first into heterodimers, and then into trimers to give the surface peplomers. SGP (secreted glycoprotein) precursor is cleaved to SGP and delta peptide, both of which are released from the cell.
* As viral protein levels rise, a switch occurs from translation to replication. Using the negative-sense genomic RNA as a template, a complementary +ssRNA is synthesized; this is then used as a template for the synthesis of new genomic (-)ssRNA, which is rapidly encapsidated.
* The newly-formed nucleocapsides and envelope proteins associate at the host cell's plasma membrane; budding occurs, and the virions are released.


==Cultural impact==
==Cultural impact==

Revision as of 15:42, 5 April 2012

For patient information click here

style="background:#Template:Taxobox colour;"|Ebola virus

style="background:#Template:Taxobox colour;" | Virus classification
Group: Group V ((-)ssRNA)
Order: Mononegavirales
Family: Filovirus
Genus: Ebolavirus
Type species
Zaïre Ebolavirus
Species

Reston Ebolavirus
Sudan Ebolavirus
Ivory Coast Ebolavirus
Bundibugyo Ebolavirus

Ebola
ICD-10 A98.4
ICD-9 065.8
DiseasesDB 18043
MedlinePlus 001339
MeSH C02.782.417.415

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Ebola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ebola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Algorithm for the Evaluation of the Returned Traveler

Emergency Department Evaluation

Case Definition

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Hospital Preparedness

Checklists

Air Medical Transport

Monitoring and Movement Following Exposure

Primary Prevention

Future or Investigational Therapies

Postmortem Care

Postmortem Care

Case Studies

Case #1

Ebola On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebola

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebola

CDC on Ebola

Ebola in the news

Blogs on Ebola

Directions to Hospitals Treating ebola

Risk calculators and risk factors for Ebola

Overview

Classification

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Causes

Differentiating Ebola

Natural history, Complications, and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory tests | Case Studies

Treatment

Medical therapy | Primary prevention | Secondary prevention | Financial costs | Future therapies


Viral reservoirs

Despite numerous studies, the wildlife reservoir of Ebolavirus has not been identified. Between 1976 and 1998, from 30,000 mammals, birds, reptiles, amphibians, and arthropods sampled from outbreak regions, no Ebolavirus was detected [1] apart from some genetic material found in six rodents (Mus setulosus and Praomys species) and a shrew (Sylvisorex ollula) collected from the Central African Republic in 1998.[2] Ebolavirus was detected in the carcasses of gorillas, chimpanzees and duikers during outbreaks in 2001 and 2003 (the carcasses were the source of the initial human infections) but the high mortality from infection in these species precludes them from acting as reservoirs.[1]

Plants, arthropods, and birds have also been considered as reservoirs, however bats are considered the most likely candidate[3]. Bats were known to reside in the cotton factory in which the index cases for the 1976 and 1979 outbreaks were employed and have also been implicated in Marburg infections in 1975 and 1980.[1] Of 24 plant species and 19 vertebrate species experimentally inoculated with Ebolavirus, only bats became infected.[4] The absence of clinical signs in these bats is characteristic of a reservoir species. In 2002-03, a survey of 1,030 animals from Gabon and the Republic of the Congo including 679 bats found Ebolavirus RNA in 13 fruit bats (Hyspignathus monstrosus, Epomops franquetti and Myonycteris torquata).[5] Bats are also known to be the reservoirs for a number of related viruses including Nipah virus, Hendra virus and lyssaviruses.

Weaponization

Because Ebola is lethal and since no approved vaccine or treatment is available, Ebola is classified as a Biosafety Level 4 agent, as well as a Category A bioterrorism agent[6] and a select agent by the CDC.

Ebola shows potential as a biological weapon because of its lethality but due to its relatively short incubation period it may be more difficult to spread since it may kill its victim before it has a chance to be transmitted, meaning that it would be hard to spread amongst small populations. However, if an outbreak occurred in a city the effects would likely be devastating.

As a terrorist weapon, Ebola has been considered by members of Japan's Aum Shinrikyo cult, whose leader, Shoko Asahara led about 40 members to Zaire in 1992 under the guise of offering medical aid to Ebola victims in what was presumably an attempt to acquire a sample of the virus.[7]

Recent outbreaks

As of August 30, 2007, 103 people (100 adults and three children) were infected by a suspected hemorrhagic fever outbreak in the village of Mweka, Democratic Republic of the Congo (DRC). The outbreak started after the funerals of two village chiefs, and 217 people in four villages fell ill. The World Health Organization sent a team to take blood samples for analysis and confirmed that many of the cases are the result of the Ebola virus [8]. The Congo's last major Ebola epidemic killed 245 people in 1995 in Kikwit, about 200 miles from the source of the Aug. 2007 outbreak.[9]

On November 30, 2007, the Uganda Ministry of Health confirmed an outbreak of Ebola in the Bundibugyo District. After confirmation of samples tested by the United States National Reference Laboratories and the Centers for Disease Control, the World Health Organization confirmed the presence of a new species of the Ebola virus.[10] The epidemic came to an official end on February 20, 2008. 149 cases of this new strain were reported and 37 of those led to deaths.

Cultural impact

An Ebola virus cuddly toy

Ebola and Marburg have served as a rich source of ideas and plotlines for many forms of entertainment. The infatuation with the virus is likely due to the high mortality rate of its victims, its mysterious nature, and its tendency to cause gruesome bleeding from bodily orifices.

In the movie Outbreak, the virus looks the same as the Ebola virus.OR In fact, the entire movie's made up virus "Motaba" is based very closely on Ebola.OR The symptoms and area of infection had relevance.

The Rage Virus from the movies 28 Days Later and 28 Weeks Later is a modified version of the Ebola virus.

In the book Outbreak, by Robin Cook, the Ebola virus is used in name as a possible weapon, with criminal intent. This book is different from the movie Outbreak of the same name

Biological warfare using airborne modifications of the Ebola virus was a main theme in Tom Clancy's novels Executive Orders and Rainbow Six.

In Resident Evil, the T-Virus is a modified version of the Progenitor Virus, created by inserting it with Ebola genes.[11]

Tomb Raider: The Cradle of Life features a biological weapon[12] consisting of a greatly accelerated form of Ebola, capable of causing death within minutes.

Much of the representation of the Ebola virus in fiction and the media is considered exaggerated or myth.[citation needed] One pervasive myth follows that the virus kills so fast that it has little time to spread. Victims die very soon after contact with the virus. In reality, the incubation time is usually about a week. The average time from onset of early symptoms to death varies in the range 3-21 days, with a mean of 10.1. Although this would prevent the transmission of the virus to many people, it is still enough time for some people to catch the disease.

Another myth states that the virus causes patients to melt, liquefy, or bleed profusely. In depictions of this type, victims of Ebola suffer from squirting blood, liquefying flesh, zombie-like faces and dramatic projectile bloody vomiting, at times, from even recently deceased. In actual fact, only a fraction of Ebola victims have severe bleeding, and most accounts of the course of the disease describe patients as dull and lethargic. Approximately 10% of patients suffer some bleeding, but this is often internal or subtle, such as bleeding from the gums. Ebola symptoms are usually limited to extreme exhaustion, vomiting, diarrhea, abdominal pain, a high fever, headaches and other body pains.

The following is an excerpt from an interview with Philippe Calain, M.D. Chief Epidemiologist, CDC Special Pathogens Branch, Kikwit 1996:

At the end of the disease the patient does not look, from the outside, as horrible as you can read in some books. They are not melting. They are not full of blood. They're in shock, muscular shock. They are not unconscious, but you would say 'obtunded', dull, quiet, very tired. Very few were hemorrhaging. Hemorrhage is not the main symptom. Less than half of the patients had some kind of hemorrhage. But the ones that had bled, died.

See also

References

  1. 1.0 1.1 1.2 Pourrut, Xavier (2005). "The natural history of Ebola virus in Africa". Microbes and Infection. 7 (7–8): 1005–1014. doi:10.1016/j.micinf.2005.04.006. Unknown parameter |coauthors= ignored (help)
  2. Morvan, Jaques (1999). "Identification of Ebola virus sequences present as RNA or DNA in organs of terrestrial small mammals of the Central African Republic". Microbes and Infection. 1 (14): 1193–1201. doi:10.1016/S1286-4579(99)00242-7. Unknown parameter |coauthors= ignored (help)
  3. "Fruit bats may carry Ebola virus". BBC News. 2005-12-11. Retrieved 2008-02-25.
  4. Swanepoel, R (1996). "Experimental inoculation of plants and animals with Ebola virus". Emerging Infectious Diseases. 2: 321–325. Unknown parameter |coauthors= ignored (help)
  5. Leroy, Eric (2005). "Fruit bats as reservoirs of Ebola virus". Nature. 438: 575–576. doi:10.1038/438575a. Unknown parameter |coauthors= ignored (help)
  6. Hoenen, Thomas (2006). "Ebola virus: unravelling pathogenesis to combat a deadly disease". Trends in Molecular Medicine. 12 (5): 206–215. doi:10.1016/j.molmed.2006.03.006. Unknown parameter |coauthors= ignored (help)
  7. Template:Cite paper
  8. "Ebola Outbreak Confirmed in Congo". NewScientist.com. 2007-09-11. Retrieved 2008-02-25.
  9. "Mystery DR Congo fever kills 100". BBC News. 2007-08-31. Retrieved 2008-02-25.
  10. "Uganda: Deadly Ebola Outbreak Confirmed - UN". UN News Service. 2007-11-30. Retrieved 2008-02-25.
  11. "Capcom.co.jp "Wesker's Report II"". Retrieved 2008-04-12.
  12. "Jesusfreakhideout.com "Lara Croft Tomb Raider: The Cradle of Life" Movie Review". Retrieved 2008-03-11.

External links

Overviews

Outbreaks

Life Cycle

Infectivity

Template:Viral diseases


Template:Jb1 Template:WH Template:WS